Abbott Completes $400M Acquisition of OptiMedica

Chicago-based Abbott has completed its $400 million buyout of OptiMedica, according to a Mass Device report.

Advertisement

Abbott reported paid $250 million up front and will cede another $150 million if several regulatory and sales milestones are met.

The acquisition brings femtosecond laser-assisted cataract surgery to Abbott Medical Optics’ ophthalmology unit.

More Articles on Ophthalmology:
Kingston Surgery Center’s Dr. Donald Savage Pens Cataract Awareness Article
Ophthalmologist Dr. David Vollman Finalist for National ‘Call to Service’ Medal
Poor Ophthalmic Clinic Infection Control to Blame for Pink Eye Outbreaks

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.